Evidence that the ability of imidazoline compounds to stimulate insulin secretion is not due to interaction with sigma receptors. (Q57942672)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 1997

edit

Language	Label	Description	Also known as
English	Evidence that the ability of imidazoline compounds to stimulate insulin secretion is not due to interaction with sigma receptors.	scientific article published in April 1997

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9128845

retrieved

1 July 2019

reference URL

http://europepmc.org/abstract/MED/9128845

title

Evidence that the ability of imidazoline compounds to stimulate insulin secretion is not due to interaction with sigma receptors. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9128845

retrieved

1 July 2019

reference URL

http://europepmc.org/abstract/MED/9128845

main subject

2-imidazoline

0 references

preproinsulin

1 reference

based on heuristic

inferred from title

author

Noel G Morgan

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9128845

retrieved

1 July 2019

reference URL

http://europepmc.org/abstract/MED/9128845

author name string

S L Chan

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9128845

retrieved

1 July 2019

reference URL

http://europepmc.org/abstract/MED/9128845

A L Pallett

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9128845

retrieved

1 July 2019

reference URL

http://europepmc.org/abstract/MED/9128845

J Clews

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9128845

retrieved

1 July 2019

reference URL

http://europepmc.org/abstract/MED/9128845

C A Ramsden

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9128845

retrieved

1 July 2019

reference URL

http://europepmc.org/abstract/MED/9128845

language of work or name

English

0 references

publication date

1 April 1997

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9128845

retrieved

1 July 2019

reference URL

http://europepmc.org/abstract/MED/9128845

published in

European Journal of Pharmacology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9128845

retrieved

1 July 2019

reference URL

http://europepmc.org/abstract/MED/9128845

volume

323

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9128845

retrieved

1 July 2019

reference URL

http://europepmc.org/abstract/MED/9128845

issue

2-3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9128845

retrieved

1 July 2019

reference URL

http://europepmc.org/abstract/MED/9128845

page(s)

241-244

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9128845

retrieved

1 July 2019

reference URL

http://europepmc.org/abstract/MED/9128845

cites work

Evidence for two different imidazoline sites on pancreatic B cells and vascular bed in rat

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900133-7

retrieved

7 January 2021

Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900133-7

retrieved

7 January 2021

Stimulation of insulin secretion by imidazoline compounds is not due to interaction with non-adrenoceptor idazoxan binding sites

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900133-7

retrieved

7 January 2021

Clotrimazole and efaroxan inhibit red cell Gardos channel independently of imidazoline I1 and I2 binding sites

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900133-7

retrieved

7 January 2021

Anaesthetic phencyclidine, blocker of the ATP-sensitive potassium channels

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900133-7

retrieved

7 January 2021

Inhibition of 5-HT3 receptor function by imidazolines in mouse neuroblastoma cells: potential involvement of sigma 2 binding sites

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900133-7

retrieved

7 January 2021

Characterization of the imidazoline binding site involved in regulation of insulin secretion.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900133-7

retrieved

7 January 2021

Clonidine and cirazoline inhibit activation of nicotinic channels in PC-12 cells.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900133-7

retrieved

7 January 2021

Imidazoli(di)ne compounds interact with the phencyclidine site of NMDA receptors in the rat brain.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900133-7

retrieved

7 January 2021

Identifiers

DOI

10.1016/S0014-2999(97)00133-7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9128845

retrieved

1 July 2019

reference URL

http://europepmc.org/abstract/MED/9128845

PubMed publication ID

9128845

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9128845

retrieved

1 July 2019

reference URL

http://europepmc.org/abstract/MED/9128845

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57942672&oldid=1373053851"